Cargando…
Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice
BACKGROUND: Cisplatin is primarily used for treatment of ovarian and testicular cancer. Oxaliplatin is the only effective treatment for metastatic colorectal cancer. Both are known to cause dose related, cumulative toxic effects on the peripheral nervous system and thirty to forty percent of cancer...
Autores principales: | Ta, Lauren E, Bieber, Allan J, Carlton, Susan M, Loprinzi, Charles L, Low, Philip A, Windebank, Anthony J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848188/ https://www.ncbi.nlm.nih.gov/pubmed/20205720 http://dx.doi.org/10.1186/1744-8069-6-15 |
Ejemplares similares
-
Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli
por: Ta, Lauren E, et al.
Publicado: (2009) -
A Novel and Selective Poly (ADP-Ribose) Polymerase Inhibitor Ameliorates Chemotherapy-Induced Painful Neuropathy
por: Ta, Lauren E., et al.
Publicado: (2013) -
Serotonin Receptor 2B Mediates Mechanical Hyperalgesia by Regulating Transient Receptor Potential Vanilloid 1
por: Su, Yeu-Shiuan, et al.
Publicado: (2015) -
Advanced oxidation protein products sensitized the transient receptor potential vanilloid 1 via NADPH oxidase 1 and 4 to cause mechanical hyperalgesia
por: Ding, Ruoting, et al.
Publicado: (2016) -
The effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel
por: Oka, Y., et al.
Publicado: (2022)